Published in:
01-03-2018 | Editorial
Recombinant growth hormone treatment, osteoporosis and fractures, more complicated than it seems!
Author:
Maria Fleseriu
Published in:
Endocrine
|
Issue 3/2018
Login to get access
Excerpt
Growth hormone (GH) effects on skeletal development are well recognized. GH promotes longitudinal bone growth during childhood and attainment of adult bone mass [
1,
2]. However, GH also plays a role in adult skeletal mass maintenance. Insulin-like growth factor 1 (IGF-1) influences development and function of several skeletal cell lineages. Independently of IGF-1, GH stimulates chondrocytes and osteoblasts; precursors of proliferation and differentiation. Simultaneously, bone resorption is mainly stimulated by IGF-1, whereas GH negatively modulates this effect by inducing the synthesis of osteoprotegerin by osteoblasts. Furthermore, GH may influence parathyroid hormone secretion pattern through phosphate retention, thus further influencing bone remodeling. …